Premium
Interplay between positive and negative elongation factors: drawing a new view of DRB
Author(s) -
Yamaguchi Yuki,
Wada Tadashi,
Handa Hiroshi
Publication year - 1998
Publication title -
genes to cells
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.912
H-Index - 115
eISSN - 1365-2443
pISSN - 1356-9597
DOI - 10.1046/j.1365-2443.1998.00162.x
Subject(s) - p tefb , biology , rna polymerase ii , transactivation , elongation factor , transcription (linguistics) , elongation , transcription factor , microbiology and biotechnology , virology , rna , genetics , gene , gene expression , promoter , ribosome , linguistics , philosophy , materials science , ultimate tensile strength , metallurgy
DRB is a classic inhibitor of transcription by RNA polymerase II (pol II). Although it has been demonstrated that DRB inhibits the elongation step of transcription, its mode of action has been elusive. DRB also markedly inhibits human immunodeficiency virus (HIV) transcription, by targeting the elongation which is enhanced by the HIV‐encoded transactivator Tat. Two factors essential for DRB action have recently been identified. These factors, positive transcription elongation factor b (P‐TEFb) and DRB sensitivity‐inducing factor (DSIF), positively and negatively regulate pol II elongation, and are likely to be relevant to the function of Tat. In this review, we summarize the recent findings on these factors, and discuss a possible model for the molecular mechanism of DRB action.